Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Hajos Parrish Ketone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116640737A reveals novel BsER mutants for asymmetric reduction. Enables cost reduction in API manufacturing with high stereoselectivity and supply reliability.
Patent CN116640737A reveals novel BsER mutants for chiral ketone reduction. Enables high-purity pharmaceutical intermediates with reduced manufacturing costs and enhanced supply reliability.